10 Cathie Wood Fate Therapeutics Trades
Cathie Wood acquired 11 Million Fate Therapeutics shares worth $294 Million. That's 1.76% of their equity portfolio (18th largest holding). The investor owns 11.9% of the outstanding Fate Therapeutics stock. The first Fate Therapeutics trade was made in Q4 2019. Since then Cathie Wood bought shares eight more times and sold shares on one occasions. The investor's estimated purchase price is $805 Million, resulting in a loss of 63%.
Avg closing price
Price range
Increased shares by 6.6% (+676 Thousand shares)
Q1 2022
Avg closing price
$38.72
Price range
$29.67
-
$60.28
Sold 5.4% shares (-590 Thousand shares)
Q4 2021
Avg closing price
$56.68
Price range
$47.84
-
$64.34
Increased shares by 45.7% (+3.42 Million shares)
Q3 2021
Avg closing price
$78.44
Price range
$59.27
-
$95.73
Increased shares by 14.2% (+929 Thousand shares)
Q2 2021
Avg closing price
$80.58
Price range
$67.25
-
$92.52
Increased shares by 125.9% (+3.65 Million shares)
Q1 2021
Avg closing price
$95.82
Price range
$72.16
-
$117.40
Increased shares by 101.5% (+1.46 Million shares)
Q4 2020
Avg closing price
$62.10
Price range
$38.09
-
$100.95
Increased shares by 41.2% (+420 Thousand shares)
Q3 2020
Avg closing price
$34.92
Price range
$30.41
-
$40.50
Increased shares by 83.7% (+465 Thousand shares)
Q2 2020
Avg closing price
$29.80
Price range
$20.21
-
$35.23
Increased shares by 28.8% (+124 Thousand shares)
Q1 2020
Avg closing price
$25.29
Price range
$17.28
-
$31.88
New holding (+431 Thousand shares)
Q4 2019
Avg closing price
$15.88
Price range
$13.39
-
$20.73
